Maternal creatine in pregnancy: a retrospective cohort study.

Dickinson, H, Davies-Tuck, M, Ellery, S J, Grieger, J A, Wallace, E M, Snow, R J, Walker, D W and Clifton, V L 2016, Maternal creatine in pregnancy: a retrospective cohort study., BJOG: an international journal of obstetrics and gynaecology, vol. 123, no. 11, pp. 1830-1838, doi: 10.1111/1471-0528.14237.

Attached Files
Name Description MIMEType Size Downloads

Title Maternal creatine in pregnancy: a retrospective cohort study.
Author(s) Dickinson, H
Davies-Tuck, M
Ellery, S J
Grieger, J A
Wallace, E M
Snow, R JORCID iD for Snow, R J orcid.org/0000-0002-4796-6916
Walker, D W
Clifton, V L
Journal name BJOG: an international journal of obstetrics and gynaecology
Volume number 123
Issue number 11
Start page 1830
End page 1838
Total pages 9
Publisher Wiley
Place of publication Chichester, Eng.
Publication date 2016-08-23
ISSN 1471-0528
Keyword(s) Fetal growth
phosphocreatine
placenta
Summary OBJECTIVE: To estimate creatine concentrations in maternal plasma and urine, and establish relationships with maternal characteristics, diet and fetal growth. DESIGN: Retrospective cohort study. SETTING: Lyell McEwin Hospital, Adelaide, Australia. POPULATION: A biobank of plasma and urine samples collected at 13, 18, 30 and 36 weeks' gestation from 287 pregnant women from a prospective cohort of asthmatic and non-asthmatic women. METHODS: Creatine was measured by enzymatic analysis. Change in creatine over pregnancy was assessed using the Friedman test. Linear mixed models regression was used to determine associations between maternal factors and diet with creatine across pregnancy and between creatine with indices of fetal growth at birth. MAIN OUTCOME MEASURES: Maternal creatine concentrations, associations between maternal factors and creatine and between creatine and fetal growth parameters. RESULTS: Maternal smoking, body mass index, asthma and socio-economic status were positively and parity negatively associated with maternal plasma and/or urine creatine. Maternal urine creatine concentration was positively associated with birthweight centile and birth length. After adjustment, each μmol/l increase in maternal urinary creatine was associated with a 1.23 (95% CI 0.44-2.02) unit increase in birthweight centile and a 0.11-cm (95% CI 0.03-0.2) increase in birth length. CONCLUSIONS: Maternal factors and fetal growth measures are associated with maternal plasma and urine creatine concentrations. TWEETABLE ABSTRACT: Maternal creatine is altered by pregnancy; fetal growth measures are associated with maternal creatine concentrations.
Language eng
DOI 10.1111/1471-0528.14237
Field of Research 110399 Clinical Sciences not elsewhere classified
Socio Economic Objective 970111 Expanding Knowledge in the Medical and Health Sciences
HERDC Research category C1 Refereed article in a scholarly journal
ERA Research output type C Journal article
Copyright notice ©2016, Wiley
Persistent URL http://hdl.handle.net/10536/DRO/DU:30085781

Document type: Journal Article
Collection: School of Exercise and Nutrition Sciences
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 3 times in TR Web of Science
Scopus Citation Count Cited 3 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 98 Abstract Views, 3 File Downloads  -  Detailed Statistics
Created: Wed, 31 Aug 2016, 09:07:11 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.